Benzinga's Top Downgrades By: Benzinga via Benzinga July 02, 2014 at 08:01 AM EDT Analysts at Barclays downgraded Bristol-Myers Squibb Company (NYSE: BMY) from “overweight” to “equal-weight.” The target price for ... Read More >> Related Stocks: Bristol-Myers Squibb Harley-Davidson Hormel Foods U.S. Bancorp